Serum changes in trace elements during thyroid cancers

被引:30
作者
Al-Sayer, H
Mathew, TC
Asfar, S
Khourshed, M
Al-Bader, A
Behbehani, A
Dashti, H
机构
[1] Kuwait Univ, Hlth Sci Ctr, Fac Med, Dept Surg, Safat 13110, Kuwait
[2] Kuwait Univ, Hlth Sci Ctr, Fac Med, Dept Anat, Safat, Kuwait
[3] Kuwait Univ, Hlth Sci Ctr, Fac Med, Dept Pathol, Safat, Kuwait
关键词
trace elements; papillary cancer; follicular cancer; thyroid cancer;
D O I
10.1023/B:MCBI.0000026027.20680.c7
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The objective was to examine changes in trace elements due to thyroid cancer in humans. Serum levels and tissue contents of trace elements (Zn, Cu, Mn, Mg, Fe and Se) were measured in 43 patients with thyroid cancer before and 4 days after surgery were compared to normal values. The serum levels of zinc in cancer patients were lower than those of normal subjects. Surgical removal of the cancer resulted in the restoration of these levels. Although serum Cu levels in patients were not different from normal, but post-operatively these levels rose significantly ( p < 0.001). Levels of Fe, Mg and Mn were significantly lower ( p < 0.001) post-operatively. There was no significant change in Serum Se levels. The thyroid tissue contents of these trace elements did not show a difference between the normal (Juxta-tumor) thyroid tissue and the cancerous lesion. Out of the six trace elements examined, the decrease of serum levels of zinc in cancer patients may be linked to the disease condition. It is suggested that this change: ( a) may be used to demonstrate successful cancer surgery and (b) may have implications for a long-term follow-up of thyroid cancer patients.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 26 条
[1]   ZINC, COPPER, MANGANESE, AND SELENIUM METABOLISM IN THYROID-DISEASE [J].
AIHARA, K ;
NISHI, Y ;
HATANO, S ;
KIHARA, M ;
YOSHIMITSU, K ;
TAKEICHI, N ;
ITO, T ;
EZAKI, H ;
USUI, T .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1984, 40 (01) :26-35
[2]  
AL-TAWEEL A Z, 1990, Medical Principles and Practice, V2, P167, DOI 10.1159/000157359
[3]   HEPATIC IODOTHYRONINE 5'-DEIODINASE - THE ROLE OF SELENIUM [J].
ARTHUR, JR ;
NICOL, F ;
BECKETT, GJ .
BIOCHEMICAL JOURNAL, 1990, 272 (02) :537-540
[4]   INHIBITION OF TYPE-I AND TYPE-II IODOTHYRONINE DEIODINASE ACTIVITY IN RAT-LIVER, KIDNEY AND BRAIN PRODUCED BY SELENIUM DEFICIENCY [J].
BECKETT, GJ ;
MACDOUGALL, DA ;
NICOL, F ;
ARTHUR, JR .
BIOCHEMICAL JOURNAL, 1989, 259 (03) :887-892
[5]   IDENTIFICATION OF TYPE-I IODOTHYRONINE 5'-DEIODINASE AS A SELENOENZYME [J].
BEHNE, D ;
KYRIAKOPOULOS, A ;
MEINHOLD, H ;
KOHRLE, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 173 (03) :1143-1149
[6]   TYPE-I IODOTHYRONINE DEIODINASE IS A SELENOCYSTEINE-CONTAINING ENZYME [J].
BERRY, MJ ;
BANU, L ;
LARSEN, PR .
NATURE, 1991, 349 (6308) :438-440
[7]   THE ROLE OF SELENIUM IN THYROID-HORMONE ACTION [J].
BERRY, MJ ;
LARSEN, PR .
ENDOCRINE REVIEWS, 1992, 13 (02) :207-219
[8]  
BOND JS, 1983, J BIOL CHEM, V258, P8004
[9]   ALTERATIONS IN MAGNESIUM AND ZINC-METABOLISM IN THYROID-DISEASE [J].
DOLEV, E ;
DEUSTER, PA ;
SOLOMON, B ;
TROSTMANN, UH ;
WARTOFSKY, L ;
BURMAN, KD .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (01) :61-67
[10]  
Flessel C P., 1979, Trace Metals in Health and Disease, P109